One such example is intestinal cancer in which the results obtained by studying human colon carcinoma samples match the observations made in mouse lines which express more stable forms of p27, namely that preventing p27 turnover represents an interesting new target for molecular cancer therapies. This evidence concerns the gene CDKN1B and colon carcinoma.